{"nct_id":"NCT03439657","title":"Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2018-04-12","start_date_type":"ACTUAL","primary_completion_date":"2019-05-06","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}